$JNJ $ITCI $ABBV #JohnsonAndJohnson #PharmaNews #NeuropsychiatricResearch #BiotechInvesting #HealthcareMergers #StockMarket #MentalHealthInnovation #CNSPortfolio #Caplyta #BristolMyers #AbbVie #MarketAnalysis Johnson & Johnson’s planned $14.6 billion acquisition of Intra-Cellular Therapies…